Strategic partnerships Daktari has an established collaboration with Merck on rapid hepatitis C screening, signaling a path to co-sell or co-develop diagnostics with large pharma partners and expand to other globally significant viruses.

Global disease focus The portable, connected point-of-care platform supports disease management in both developed and developing markets, presenting cross-border sales opportunities with health systems, NGOs, and public health programs aiming for disease elimination.

Digital ecosystem Built-in wireless connectivity and cloud-based data management enable real-time outcomes and remote monitoring, offering upsell potential for data services, analytics subscriptions, and managed services alongside device sales.

Funded growth With substantial funding and a revenue range indicative of growing commercial activity, there is readiness for regional market expansion, channel development, and strategic hires to accelerate go-to-market efforts.

Healthcare segments Target viruses of worldwide significance (Hepatitis C and HIV) align with high-need clinics and lab networks, suggesting sales opportunities through hospital systems, reference labs, and public health initiatives seeking rapid diagnostics.